Caliber Wealth Management LLC KS lessened its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 15.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,027 shares of the financial services provider's stock after selling 2,151 shares during the quarter. Caliber Wealth Management LLC KS's holdings in CME Group were worth $3,315,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. GQG Partners LLC lifted its stake in CME Group by 7,676.3% in the first quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after buying an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after purchasing an additional 2,089,935 shares during the period. Nuveen LLC acquired a new stake in shares of CME Group in the first quarter valued at approximately $218,842,000. Alliancebernstein L.P. boosted its position in CME Group by 185.5% during the first quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock worth $330,182,000 after purchasing an additional 808,740 shares during the period. Finally, Egerton Capital UK LLP grew its stake in CME Group by 79.4% in the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider's stock valued at $459,003,000 after buying an additional 765,773 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the stock. Morgan Stanley upped their price target on shares of CME Group from $303.00 to $312.00 and gave the company an "overweight" rating in a research note on Wednesday, October 1st. Oppenheimer boosted their price target on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Wall Street Zen downgraded shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. JPMorgan Chase & Co. boosted their price target on CME Group from $252.00 to $256.00 and gave the stock an "underweight" rating in a report on Tuesday, October 14th. Finally, Raymond James Financial decreased their price objective on CME Group from $309.00 to $307.00 and set an "outperform" rating for the company in a report on Monday, October 13th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $283.71.
View Our Latest Report on CME
Insider Transactions at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares of the company's stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. Corporate insiders own 0.30% of the company's stock.
CME Group Stock Up 0.4%
Shares of CME Group stock opened at $268.61 on Wednesday. The stock's 50-day moving average is $266.80 and its 200 day moving average is $271.48. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The firm has a market cap of $96.80 billion, a price-to-earnings ratio of 26.00, a PEG ratio of 6.16 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's revenue was down 3.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.68 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group's payout ratio is 48.40%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report